Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.
Transmissible encephalopathies (TSEs), such as Creutzfeldt-Jakob disease (CJD) and scrapie, are caused by infectious agents that provoke strain-specific patterns of disease. Misfolded host prion protein (PrP-res amyloid) is believed to be the causal infectious agent. However, particles that are stripped of PrP retain both high infectivity and viral proteins not detectable in uninfected mouse controls. We here detail host proteins bound with FU-CJD agent infectious brain particles by proteomic analysis. More than 98 proteins were differentially regulated, and 56 FU-CJD exclusive proteins were revealed after PrP, GFAP, C1q, ApoE, and other late pathologic response proteins were removed. Stripped FU-CJD particles revealed HSC70 (144× the uninfected control), cyclophilin B, an FU-CJD exclusive protein required by many viruses, and early endosome-membrane pathways known to facilitate viral processing, replication, and spread. Synaptosomal elements including synapsin-2 (at 33×) and AP180 (a major FU-CJD exclusive protein) paralleled the known ultrastructural location of 25 nm virus-like TSE particles and infectivity in synapses. Proteins without apparent viral or neurodegenerative links (copine-3), and others involved in viral-induced protein misfolding and aggregation, were also identified. Human sCJD brain particles contained 146 exclusive proteins, and heat shock, synaptic, and viral pathways were again prominent, in addition to Alzheimer, Parkinson, and Huntington aggregation proteins. Host proteins that bind TSE infectious particles can prevent host immune recognition and contribute to prolonged cross-species transmissions (the species barrier). Our infectious particle strategy, which reduces background sequences by >99%, emphasizes host targets for new therapeutic initiatives. Such therapies can simultaneously subvert common pathways of neurodegeneration.
Yale University Medical School, New Haven, CT, USA.
Terry
T
Kipkorir
Yale University Medical School, New Haven, CT, USA.
Christopher M
CM
Colangelo
Yale University Medical School, New Haven, CT, USA.
Laura
L
Manuelidis
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D016022:Case-Control Studies; D007562:Creutzfeldt-Jakob Syndrome / Q000378:metabolism*; D050763:Cyclin-Dependent Kinase Inhibitor p18 / Q000378:metabolism; D021983:Cyclophilins / Q000378:metabolism; D050883:HSC70 Heat-Shock Proteins / Q000378:metabolism; D006801:Humans; D051379:Mice; D011328:Prions / Q000378:metabolism; D011506:Proteins / Q000032:analysis / Q000378:metabolism*; D040901:Proteomics / Q000379:methods
C493971:CDKN2C protein, human; D050763:Cyclin-Dependent Kinase Inhibitor p18; D050883:HSC70 Heat-Shock Proteins; C494371:HSPA8 protein, human; C494372:Hspa8 protein, mouse; D011328:Prions; D011506:Proteins; C081786:cyclophilin B; D021983:Cyclophilins
Amyloid; Chaperones; Early endosomes; Microbiology; Synapses; Viral transit